ALLUME Trademark

Trademark Overview

On Thursday, June 21, 2012, a trademark application was filed for ALLUME with the United States Patent and Trademark Office. The USPTO has given the ALLUME trademark a serial number of 85657600. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 5, 2020. This trademark is owned by Quintiles Transnational Corp.. The ALLUME trademark is filed in the Advertising, Business and Retail Services category with the following description:

Providing project management services for others for business purposes related to the market introduction of new products in the fields of pharmaceutical, pharmacogenomics, biotechnology, and medical products and devices; business evaluation of business processes for the market introduction of new products in the fields of pharmaceutical, pharmacogenomics, biotechnology, and medical products and devices; market assessment services for the market introduction of new products in the fields of pharmaceutical, pharmacogenomics, biotechnology, and medical products and devices; development of marketing strategies and concepts and business marketing consulting services featuring marketing strategies and marketing techniques for products in the fields of pharmaceutical, pharmacogenomics, biotechnology, and medical products and devices
allume

General Information

Serial Number85657600
Word MarkALLUME
Filing DateThursday, June 21, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 5, 2020
Registration Number4415718
Registration DateTuesday, October 8, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2013

Trademark Statements

Goods and ServicesProviding project management services for others for business purposes related to the market introduction of new products in the fields of pharmaceutical, pharmacogenomics, biotechnology, and medical products and devices; business evaluation of business processes for the market introduction of new products in the fields of pharmaceutical, pharmacogenomics, biotechnology, and medical products and devices; market assessment services for the market introduction of new products in the fields of pharmaceutical, pharmacogenomics, biotechnology, and medical products and devices; development of marketing strategies and concepts and business marketing consulting services featuring marketing strategies and marketing techniques for products in the fields of pharmaceutical, pharmacogenomics, biotechnology, and medical products and devices

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 5, 2020
Primary Code035
First Use Anywhere DateSaturday, June 30, 2012
First Use In Commerce DateSaturday, June 30, 2012

Trademark Owner History

Party NameQuintiles Transnational Corp.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703
Party NameQuintiles Transnational Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27703
Party NameQuintiles Transnational Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Trademark Events

Event DateEvent Description
Friday, June 5, 2020CANCELLED SEC. 8 (6-YR)
Monday, October 8, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, October 12, 2016ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, May 27, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, May 20, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, November 17, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 8, 2013REGISTERED-PRINCIPAL REGISTER
Thursday, September 5, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, September 4, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, September 4, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 27, 2013STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 24, 2013USE AMENDMENT FILED
Monday, August 26, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 24, 2013TEAS STATEMENT OF USE RECEIVED
Tuesday, June 18, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 23, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2013PUBLISHED FOR OPPOSITION
Wednesday, April 3, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 18, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, March 16, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 6, 2013ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, March 5, 2013EXAMINER'S AMENDMENT ENTERED
Tuesday, March 5, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 5, 2013EXAMINERS AMENDMENT E-MAILED
Tuesday, March 5, 2013EXAMINERS AMENDMENT -WRITTEN
Thursday, February 28, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 28, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, February 24, 2013ASSIGNED TO LIE
Thursday, February 21, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 27, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 27, 2012NON-FINAL ACTION E-MAILED
Monday, August 27, 2012NON-FINAL ACTION WRITTEN
Friday, August 17, 2012ASSIGNED TO EXAMINER
Thursday, June 28, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, June 25, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

allume products pharmaceutical fields biotechnology medical marketing devices market pharmacogenomics business